CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 1,020,921 Value ($000) $41,745 Avg Close — Range —
Q1 2024
Shares 1,016,976 Value ($000) $42,988 Avg Close — Range —
Q4 2023
Shares 532,757 Value ($000) $22,589 Avg Close — Range —
Q3 2023
Shares 324,499 Value ($000) $7,084 Avg Close — Range —
Q2 2023
Shares 363,704 Value ($000) $11,562 Avg Close — Range —
Q1 2023
Shares 377,057 Value ($000) $9,196 Avg Close — Range —
Q4 2022
Shares 306,950 Value ($000) $9,681 Avg Close — Range —
Q3 2022
Shares 245,797 Value ($000) $7 Avg Close — Range —
Q2 2022
Shares 101,104 Value ($000) $3 Avg Close — Range —
Q1 2022
Shares 82,265 Value ($000) $2,880 Avg Close — Range —
Q4 2021
Shares 421,688 Value ($000) $13,671 Avg Close — Range —
Q3 2021
Shares 509,747 Value ($000) $15,038 Avg Close — Range —
Q1 2021
Shares 190,266 Value ($000) $2,612 Avg Close — Range —
Q4 2020
Shares 28,309 Value ($000) $469 Avg Close — Range —